OpenURL Connection Search

Select item for more details and to access through your institution.

Sofosbuvir–velpatasvir in adults with hepatitis C virus infection and compensated cirrhosis in Japan.
Published in:
Hepatology Research, 2022, v. 52, n. 10, p. 833, doi. 10.1111/hepr.13810
By:
- Takehara, Tetsuo;
- Izumi, Namiki;
- Mochida, Satoshi;
- Genda, Takuya;
- Fujiyama, Shigetoshi;
- Notsumata, Kazuo;
- Tamori, Akihiro;
- Suzuki, Fumitaka;
- Suri, Vithika;
- Mercier, Renee‐Claude;
- Matsuda, Takuma;
- Matsuda, Kana;
- Kato, Naoya;
- Chayama, Kazuaki;
- Kumada, Hiromitsu
Publication type:
Article
Sofosbuvir/velpatasvir and glecaprevir/pibrentasvir: how should we choose among these two latest and probably the last regimens?
Published in:
Hepatology Research, 2022, v. 52, n. 10, p. 815, doi. 10.1111/hepr.13828
Publication type:
Article
Real‐world outcomes of molecular targeted agents for patients with hepatocellular carcinoma over 80 years old.
Published in:
Hepatology Research, 2022, v. 52, n. 10, p. 859, doi. 10.1111/hepr.13818
By:
- Sato, Rui;
- Moriguchi, Michihisa;
- Iwai, Kenji;
- Tsuchiya, Satoshi;
- Seko, Yuya;
- Takahashi, Aya;
- Kobayashi, Kazufumi;
- Ogasawara, Sadahisa;
- Watanabe, Shunji;
- Morimoto, Naoki;
- Kato, Naoya;
- Itoh, Yoshito;
- Aramaki, Takeshi
Publication type:
Article
Frequency of null genotypes of glutathione S‐transferase M1 and T1 in Japanese patients with drug‐induced liver injury.
Published in:
Hepatology Research, 2022, v. 52, n. 10, p. 882, doi. 10.1111/hepr.13812
By:
- Maeda, Kazuya;
- Takikawa, Hajime;
- Aiso, Mitsuhiko;
- Tsuji, Kenji;
- Kagawa, Tatehiro;
- Watanabe, Masaaki;
- Sato, Ken;
- Sakisaka, Shotaro;
- Hiasa, Yoichi;
- Takei, Yoshiyuki;
- Ohira, Hiromasa;
- Hashimoto, Etsuko;
- Ayada, Minoru;
- Ikegami, Tadashi;
- Arakawa, Noriaki;
- Kusuhara, Hiroyuki;
- Saito, Yoshiro;
- Sugiyama, Yuichi
Publication type:
Article
Progression from early to advanced stage of immune‐related cholangitis.
Published in:
Hepatology Research, 2022, v. 52, n. 10, p. 888, doi. 10.1111/hepr.13817
By:
- Hagiwara, Satoru;
- Yoshida, Takeshi;
- Nishida, Naoshi;
- Ida, Hiroshi;
- Ueshima, Kazuomi;
- Minami, Yasunori;
- Takita, Masahiro;
- Aoki, Tomoko;
- Morita, Masahiro;
- Cishina, Hirokazu;
- Komeda, Yoriaki;
- Yoshida, Akihiro;
- Hayashi, Hidetoshi;
- Nakagawa, Kazuhiko;
- Kudo, Masatoshi
Publication type:
Article
Corrigendum.
Published in:
2022
Publication type:
Correction Notice
Low syntaxin 17 expression in donor liver is associated with poor graft prognosis in recipients of living donor liver transplantation.
Published in:
Hepatology Research, 2022, v. 52, n. 10, p. 872, doi. 10.1111/hepr.13809
By:
- Tomiyama, Takahiro;
- Shimokawa, Masahiro;
- Harada, Noboru;
- Toshida, Katsuya;
- Morinaga, Akinari;
- Kosai‐Fujimoto, Yukiko;
- Tomino, Takahiro;
- Kurihara, Takeshi;
- Nagao, Yoshihiro;
- Toshima, Takeo;
- Morita, Kazutoyo;
- Itoh, Shinji;
- Yoshizumi, Tomoharu
Publication type:
Article
Metabolic dysfunction‐associated fatty liver disease directly related to liver fibrosis independent of insulin resistance, hyperlipidemia, and alcohol intake in morbidly obese patients.
Published in:
Hepatology Research, 2022, v. 52, n. 10, p. 841, doi. 10.1111/hepr.13808
By:
- Inamine, Susumu;
- Kage, Masayoshi;
- Akiba, Jun;
- Kawaguchi, Takumi;
- Yoshio, Sachiyo;
- Kawaguchi, Machiko;
- Nakano, Dan;
- Tsutsumi, Tsubasa;
- Hashida, Ryuki;
- Oshiro, Kouichi
Publication type:
Article
Risk of hepatocellular carcinoma after sustained virologic response in hepatitis C virus patients without advanced liver fibrosis.
Published in:
Hepatology Research, 2022, v. 52, n. 10, p. 824, doi. 10.1111/hepr.13806
By:
- Tahata, Yuki;
- Sakamori, Ryotaro;
- Yamada, Ryoko;
- Kodama, Takahiro;
- Hikita, Hayato;
- Nozaki, Yasutoshi;
- Oshita, Masahide;
- Hiramatsu, Naoki;
- Miyazaki, Masanori;
- Mita, Eiji;
- Yamamoto, Keiji;
- Ohkawa, Kazuyoshi;
- Kaneko, Akira;
- Ito, Toshifumi;
- Doi, Yoshinori;
- Yakushijin, Takayuki;
- Hijioka, Taizo;
- Fukui, Hiroyuki;
- Imanaka, Kazuho;
- Yoshida, Yuichi
Publication type:
Article
Anatomical thermal ablation: A valuable treatment method for hepatocellular carcinoma smaller than 5 cm.
Published in:
Hepatology Research, 2022, v. 52, n. 10, p. 893, doi. 10.1111/hepr.13805
By:
- Sun, Hang;
- Xu, Wei;
- Yang, Huayu
Publication type:
Article
Robust antiviral responses in severe hepatitis flare persist after early retreatment cessation and lead toward hepatitis B surface antigen loss: A proof‐of‐concept study.
Published in:
Hepatology Research, 2022, v. 52, n. 10, p. 817, doi. 10.1111/hepr.13804
By:
- Chang, Ming‐Ling;
- Chien, Rong‐Nan;
- Liaw, Yun‐Fan
Publication type:
Article
Issue Information.
Published in:
Hepatology Research, 2022, v. 52, n. 10, p. 813, doi. 10.1111/hepr.13661
Publication type:
Article

Found: 12